TY - JOUR
T1 - Coupled models of genomic surveillance and evolving pandemics with applications for timely public health interventions
AU - Espinoza, Baltazar
AU - Adiga, Aniruddha
AU - Venkatramanan, Srinivasan
AU - Warren, Andrew Scott
AU - Chen, Jiangzhuo
AU - Lewis, Bryan Leroy
AU - Vullikanti, Anil
AU - Swarup, Samarth
AU - Moon, Sifat
AU - Barrett, Christopher Louis
AU - Athreya, Siva
AU - Sundaresan, Rajesh
AU - Chandru, Vijay
AU - Laxminarayan, Ramanan
AU - Schaffer, Benjamin
AU - Poor, H. Vincent
AU - Levin, Simon A.
AU - Marathe, Madhav V.
N1 - Publisher Copyright:
Copyright © 2023 the Author(s).
PY - 2023
Y1 - 2023
N2 - Disease surveillance systems provide early warnings of disease outbreaks before they become public health emergencies. However, pandemics containment would be challenging due to the complex immunity landscape created by multiple variants. Genomic surveillance is critical for detecting novel variants with diverse characteristics and importation/emergence times. Yet, a systematic study incorporating genomic monitoring, situation assessment, and intervention strategies is lacking in the literature. We formulate an integrated computational modeling framework to study a realistic course of action based on sequencing, analysis, and response. We study the effects of the second variant’s importation time, its infectiousness advantage and, its cross-infection on the novel variant’s detection time, and the resulting intervention scenarios to contain epidemics driven by two-variants dynamics. Our results illustrate the limitation in the intervention’s effectiveness due to the variants’ competing dynamics and provide the following insights: i) There is a set of importation times that yields the worst detection time for the second variant, which depends on the first variant’s basic reproductive number; ii) When the second variant is imported relatively early with respect to the first variant, the cross-infection level does not impact the detection time of the second variant. We found that depending on the target metric, the best outcomes are attained under different interventions’ regimes. Our results emphasize the importance of sustained enforcement of Non-Pharmaceutical Interventions on preventing epidemic resurgence due to importation/emergence of novel variants. We also discuss how our methods can be used to study when a novel variant emerges within a population.
AB - Disease surveillance systems provide early warnings of disease outbreaks before they become public health emergencies. However, pandemics containment would be challenging due to the complex immunity landscape created by multiple variants. Genomic surveillance is critical for detecting novel variants with diverse characteristics and importation/emergence times. Yet, a systematic study incorporating genomic monitoring, situation assessment, and intervention strategies is lacking in the literature. We formulate an integrated computational modeling framework to study a realistic course of action based on sequencing, analysis, and response. We study the effects of the second variant’s importation time, its infectiousness advantage and, its cross-infection on the novel variant’s detection time, and the resulting intervention scenarios to contain epidemics driven by two-variants dynamics. Our results illustrate the limitation in the intervention’s effectiveness due to the variants’ competing dynamics and provide the following insights: i) There is a set of importation times that yields the worst detection time for the second variant, which depends on the first variant’s basic reproductive number; ii) When the second variant is imported relatively early with respect to the first variant, the cross-infection level does not impact the detection time of the second variant. We found that depending on the target metric, the best outcomes are attained under different interventions’ regimes. Our results emphasize the importance of sustained enforcement of Non-Pharmaceutical Interventions on preventing epidemic resurgence due to importation/emergence of novel variants. We also discuss how our methods can be used to study when a novel variant emerges within a population.
KW - COVID-19 variants
KW - biosurveillance
KW - coupled dynamics
KW - epidemic modeling
KW - pandemics
UR - http://www.scopus.com/inward/record.url?scp=85178168065&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85178168065&partnerID=8YFLogxK
U2 - 10.1073/pnas.2305227120
DO - 10.1073/pnas.2305227120
M3 - Article
C2 - 37983514
AN - SCOPUS:85178168065
SN - 0027-8424
VL - 120
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 48
M1 - e2305227120
ER -